A detailed history of Umb Bank, N.A. transactions in Organon & Co. stock. As of the latest transaction made, Umb Bank, N.A. holds 1,444 shares of OGN stock, worth $22,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,444
Previous 891 62.07%
Holding current value
$22,468
Previous $17,000 23.53%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$14.44 - $18.83 $7,985 - $10,412
553 Added 62.07%
1,444 $21,000
Q3 2024

Oct 08, 2024

BUY
$18.65 - $23.03 $11,096 - $13,702
595 Added 201.01%
891 $17,000
Q2 2024

Jul 29, 2024

SELL
$17.45 - $21.96 $1,047 - $1,317
-60 Reduced 16.85%
296 $6,000
Q1 2024

Apr 26, 2024

SELL
$13.78 - $18.8 $23,426 - $31,960
-1,700 Reduced 82.68%
356 $6,000
Q4 2023

Jan 23, 2024

BUY
$10.95 - $17.32 $1,642 - $2,598
150 Added 7.87%
2,056 $29,000
Q3 2023

Oct 18, 2023

SELL
$16.59 - $23.77 $5,474 - $7,844
-330 Reduced 14.76%
1,906 $33,000
Q2 2023

Jul 25, 2023

SELL
$19.27 - $24.63 $77 - $98
-4 Reduced 0.18%
2,236 $46,000
Q1 2023

Apr 11, 2023

SELL
$21.42 - $32.08 $1,649 - $2,470
-77 Reduced 3.32%
2,240 $52,000
Q4 2022

Jan 10, 2023

BUY
$23.31 - $28.61 $932 - $1,144
40 Added 1.76%
2,317 $64,000
Q3 2022

Oct 13, 2022

SELL
$23.4 - $34.25 $2,152 - $3,151
-92 Reduced 3.88%
2,277 $53,000
Q2 2022

Jul 20, 2022

SELL
$31.66 - $38.9 $76,997 - $94,604
-2,432 Reduced 50.66%
2,369 $80,000
Q1 2022

Apr 22, 2022

SELL
$30.45 - $39.36 $94,395 - $122,016
-3,100 Reduced 39.24%
4,801 $168,000
Q4 2021

Feb 09, 2022

SELL
$28.67 - $37.13 $104,989 - $135,970
-3,662 Reduced 31.67%
7,901 $241,000
Q3 2021

Oct 18, 2021

SELL
$28.63 - $35.64 $150,278 - $187,074
-5,249 Reduced 31.22%
11,563 $379,000
Q2 2021

Jul 26, 2021

BUY
$28.45 - $38.0 $478,301 - $638,856
16,812 New
16,812 $508,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.